Zdrowie i gospodarka · 16/02/2016
FDA Announces Draft Guidance for Allergic Rhinitis Treatment
The FDA is releasing a draft guidance to help pharmaceutical companies develop effective treatments for seasonal and perennial allergic rhinitis, building on previous guidance issued in 2000.
Source: Federal Register — Food and Drug AdministrationOpen original release →